Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in YARW — Yarrow Bioscience, Inc.

CIK 1214717 BOSTON, MA
Back to YARW Full portfolio

Position in YARW

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$168,089
-$24,891 QoQ
Shares Held
5,164
-20.0% QoQ
Ownership
0.193%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 44 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in YARW Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. YARW ranks #414 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in YARW

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $168,089 258,203
2026-03-31 $192,980 322,711
2025-12-31 $130,587 225,152
2025-09-30 $45,935 137,122
2025-06-30 $219,992 133,329
2025-03-31 $210,913 133,490
2024-12-31 $452,306 135,017
2024-09-30 $253,028 134,590
2024-06-30 $267,269 135,670
2024-03-31 $327,799 106,775
2023-12-31 $219,819 94,343
2023-09-30 $111,237 27,534
2023-06-30 $102,274 24,945
2023-03-31 $76,830 24,945